Last updated: August 17, 2026

Examiner: COUGHLIN, DANIEL F

Tech Center 3700 • Art Units: 1619 1629 3791

This examiner grants 39% of resolved cases

Performance Statistics

39.0%

Allow Rate

-31.0% vs TC avg

554

Total Applications

+18.5%

Interview Lift

1339

Avg Prosecution Days

Based on 516 resolved cases, 2023–2026

0.4%

§101 Eligibility

14.3%

§102 Novelty

62.9%

§103 Obviousness

5.3%

§112 Clarity

App #	Title	Status	Assignee
18793507	PLATE-DERIVED GROWTH FACTOR FORMULATION FOR ENHANCING BONE FUSION	Non-Final OA	STRYKER CORPORATION
18674990	METHODS AND COMPOSITIONS FOR TREATING SPINAL CORD INJURY	Non-Final OA	Ramot at Tel-Aviv University Ltd.
18370598	COMPOSITION FOR IMMUNE TREATMENT OF ALLERGIC DISEASES COMPRISING HOUSE DUST MITE ANTIGENS AND HYALURONIC ACID HYDROGELS AS ACTIVE INGREDIENTS	Non-Final OA	THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.